Suscriptores   Asóciese  
Textos Completos Autorizados
BIOPSIA ESTEREOTAXICA DIRIGIDA POR ESTUDO DE PERFUSAO POR RM

v-estudie-lo-mejor.gif
Expertos Invitados





BIOPSIA ESTEREOTAXICA DIRIGIDA POR ESTUDO DE PERFUSAO POR RM

(especial para SIIC © Derechos reservados)
A seqüência de perfusão por RM é um método acessível, que pode potencialmente reduzir os erros de amostragem nos procedimentos de biópsia estereotáxica em gliomas sem impregnação pelo Gd e pode ser utilizada como critério adicional aos morfológicos na graduação pré-operatória dos tumores gliais, excluindo a possibilidade de anaplasia quando os valores de rCBV são menores que 1,2.
Autor:
Antonio Carlos Martins Maia Jr
Columnista Experto de SIIC

Institución:
Centro de Medicina Diagnóstica Fleury, Paraíso, Brasil

Artículos publicados por Antonio Carlos Martins Maia Jr
Coautores
Antonio Carlos Martins Maia Jr*  Suzana Maria Fleury Malheiros**  Antonio José Da Rocha*** 
Radiologista, Centro de Medicina Diagnóstica Fleury, Neuroradiologista*
Médica, Universidade Federal de São Paulo, Neurologista**
Médico, Centro de Medicina Diagnóstica Fleury, Neuroradiologista***
Aprobación
22 de Febrero, 2005 		Primera edición
29 de Julio, 2005 		Segunda edición, ampliada y corregida
7 de Junio, 2021

BIOPSIA ESTEREOTAXICA DIRIGIDA POR ESTUDO DE PERFUSAO POR RM


Artículo completo
(castellano)
Extensión:  +/-3.02 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes
Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Diagnóstico por Imágenes, Neurocirugía
Relacionadas: Anatomía Patológica, Oncología



Comprar este artículo
Extensión: 3.02 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Bibliografía del artículo
Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet 2003;361(9354):323-331.Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24(10):1989-1998.Moller-Hartmann W, Herminghaus S, Krings T, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44(5):371-381.Dean B, Drayer B, Bird C, et al. Gliomas: classification with MR imaging. Radiology 1990;174(2):411-415.Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992;34(6):463-469.Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993;79(4):533-536.Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211(3):791-798.Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 1998;49(4):436-440.Barker FG, 2nd, Chang SM, Huhn SL, et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 1997;80(5):936-941.DeAngelis LM. Brain tumors. N Engl J Med 2001;344(2):114-123.Uematsu H, Maeda M, Sadato N, et al. Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. AJNR Am J Neuroradiol 2001;22(10):1915-1919.Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21(5):901-909.Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191(1):41-51.Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178(3):711-716.Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171(6):1479-1486.Cha S, Knopp EA, Johnson G, et al. Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol 2000;21(5):881-890.Lam WW, Chan KW, Wong WL, Poon WS, Metreweli C. Pre-operative grading of intracranial glioma. Acta Radiol 2001;42(6):548-554.Davis FG, Preston-Martin S. Epidemiology. Incidence and survival. In: Bigner DD, McLendon RE, Bruner JM, eds. Russel and Rubinstein's Pathology of Tumors of the Nervous System. 6 ed. London: Arnold, 1998; 5-45.Felix R, Schorner W, Laniado M, et al. Brain tumors: MR imaging with gadolinium-DTPA. Radiology 1985;156(3):681-688.Daumas-Duport C, Monsaigneon V, Blond S, et al. Serial stereotactic biopsies and CT scan in gliomas: correlative study in 100 astrocytomas, oligo-astrocytomas and oligodendrocytomas. J Neurooncol 1987;4(4):317-328.Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223(1):11-29.Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 1999;9(2):309-331.Aronen HJ, Perkio J. Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am 2002;12(4):501-523.Aronen HJ, Pardo FS, Kennedy DN, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000;6(6):2189-2200.Lee SJ, Kim JH, Kim YM, et al. Perfusion MR imaging in gliomas: comparison with histologic tumor grade. Korean J Radiol 2001;2(1):1-7.Lev MH, Ozsunar Y, Henson JW, et al. Glial Tumor Grading and Outcome Prediction Using Dynamic Spin-Echo MR Susceptibility Mapping Compared with Conventional Contrast-Enhanced MR: Confounding Effect of Elevated rCBV of Oligodendroglimoas. AJNR Am J Neuroradiol 2004;25(2):214-221.Cha S, Tihan T, Crawford F, et al. Differentiation of Low-Grade Oligodendrogliomas from Low-Grade Astrocytomas by Using Quantitative Blood-Volume Measurements Derived from Dynamic Susceptibility Contrast-Enhanced MR Imaging. AJNR Am J Neuroradiol 2005;26(2):266-273.Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic Intraaxial Brain Tumor: The Value of Perfusion-sensitive Contrast-enhanced MR Imaging for Differentiating Tumor Recurrence from Nonneoplastic Contrast-enhancing Tissue. AJNR Am J Neuroradiol 2000;21(5):901-909.Bouza AA. Desenvolvimento de uma técnica para fusão de imagens para planejamento cirúrgico em condições estereotáxicas. [Tese de Mestrado em Neurociências]. São Paulo - Brasil: Universidade Federal de São Paulo - UNIFESP - EPM; 1999.Cairncross JG, Laperriere NJ. Low-grade glioma. To treat or not to treat Arch Neurol 1989;46(11):1238-1239.Scott JN, Rewcastle NB, Brasher PM, et al. Which glioblastoma multiforme patient will become a long-term survivor A population-based study. Ann Neurol 1999;46(2):183-188.Chandrasoma PT, Smith MM, Apuzzo ML. Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery 1989;24(2):160-165.Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990;31(6):965-969.Padma MV, Said S, Jacobs M, et al. Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 2003;64(3):227-237.Tsuyuguchi N, Sunada I, Iwai Y, et al. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible J Neurosurg 2003;98(5):1056-1064.Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP. Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 1997;34(1):37-59.Alvord E, Shaw C-M, Richards T. The relative rates of cellular proliferation and infiltration and the histologic definition of gliomas. Can J Neurol Sci 1993;20(83).Sage MR. Blood-brain barrier: phenomenon of increasing importance to the imaging clinician. AJR Am J Roentgenol 1982;138(5):887-898.Chan AS, Leung SY, Wong MP, et al. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. Am J Surg Pathol 1998;22(7):816-826.Watanabe T, Nakamura M, Kros JM, et al. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas. Acta Neuropathol (Berl) 2002;103(3):267-275.
Título español
 Bibliografía
 Artículo completo
(exclusivo a suscriptores)
 Autoevaluación
  Tema principal en SIIC Data Bases
 Especialidades

  English title
  Abstract
  Key words
Full text
(exclusivo a suscriptores)

Autor 
Artículos
Correspondencia

Patrocinio y reconocimiento
Imprimir esta página
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Acerca de SIIC   Estructura de SIIC   Fuentes informativas  

Sociedad Iberoamericana de Información Científica

Copyright siicsalud© 1997-2024 ISSN siicsalud: 1667-9008
ua31517